Paper
7 August 2019 A pilot study of antimicrobial photodynamic therapy of encapsulated Aspergillus fumigatus in a rabbit maxillary sinus model
Author Affiliations +
Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 110708J (2019) https://doi.org/10.1117/12.2526225
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States
Abstract
Aspergillus fumigatus is the most common isolated agent in chronic invasive fungal rhinosinusitis with patients enduring painful and recurrent sinus symptoms. Prompt diagnosis and initiation of appropriate therapy is essential to avoid a protracted or fatal outcome. Our group has developed a novel methylene blue-based photodynamic therapy approach to treatment of Aspergillus rhinosinusitis. Briefly, A. fumigatus was encapsulated within 250μm agar beads in a validated model and titrated into the rabbit maxillary sinus. A. fumigatus burden after Sinuwave™ antimicrobial photodynamic therapy was compared to control, with > 99.9% reduction in recoverable fungus, a highly significant outcome.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
C. Romo, N. Loebel, D. Meller, and R. Andersen "A pilot study of antimicrobial photodynamic therapy of encapsulated Aspergillus fumigatus in a rabbit maxillary sinus model", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110708J (7 August 2019); https://doi.org/10.1117/12.2526225
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
In vivo imaging

Photodynamic therapy

Picosecond phenomena

In vitro testing

Diffusers

Personal digital assistants

Chemical elements

Back to Top